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Background:  Single ventricle (SV) congenital heart disease patients often form abnormal aortopulmonary collateral (APC) blood 
vessels via an unclear mechanism. Prior studies separately showed elevated hypoxia-inducible angiogenic factor levels such as vascular 
endothelial growth factor (VEGF) in SV serum and the ability of SV serum to stimulate endothelial cells to form simple tubules in vitro. 
However, no study has correlated angiogenic factor levels with in vitro activity and angiography. We examined whether SV patients with 
APCs have increased angiogenic factors that can stimulate endothelial sprouting in vitro.
methods:  In single ventricle (n=17) and biventricular acyanotic control patients (n=13), VEGF and other plasma angiogenic factor levels 
were measured in femoral venous and arterial blood at cardiac catheterization. To assess plasma angiogenic activity, we developed a 3-D 
in vitro endothelial cell sprouting assay that recapitulates angiogenic sprouting, a possible key step in APC formation.
results:  Angiogenic activity of SV patients was not significantly greater than controls. While some SV patients had elevated plasma 
VEGF, average levels were not significantly different from controls. SV plasma also did not stimulate cells to form significantly more sprouts 
than control plasma. Plasma factor levels and the number of cell sprouts formed correlated poorly with APC severity. However, arterial 
soluble fms-like tyrosine kinase-1 (sFlt-1), a regulatory VEGF receptor, was significantly elevated in SV patients (550±94 pg/mL) versus 
controls (238±32 pg/mL) (p < 0.01).
Conclusion:  Our ongoing study is the first to simultaneously correlate angiography with plasma angiogenic factor levels and in vitro 
angiogenic activity in SV patients with APCs. Surprisingly, preliminary data show that SV patients with APCs have a wide range of factor 
levels and angiogenic activity that correlates poorly with APC severity suggesting a complex mechanism of angiogenesis. Arterial sFlt-1 is 
elevated in SV patients and may have a role in APC formation that requires further investigation.
